BUY Oil India — Madhu Bansal
byMadhu BansalHorizon: NA (inferred Swing (≤2wk))14 May 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days
Advisor consensus · same horizon·19 May · today
3 advisors have active short-term BUY calls on this stock, all issued in the last 14 days
Advisor consensus · adjacent horizon·14 May · 4d ago
Oil India reported a 62% growth in consolidated PAT for Q4 FY26 to ₹2,424 crore and a 7% growth for the full year to ₹7,551 crore. The company also announced a final dividend of ₹1.00 per share and ac
NSE · Press Release·13 May · 5d ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Oil India
- BUY — Kunal Saraogi21 Oct 2026 · ~2 weeks · target ₹480 · Active
- SELL — Kotak Securities2 Oct 2026 · ~1 year · target ₹360 · Active
- BUY — Aditya Agarwal, Coheron Brokers21 Sept 2026 · ~3 months · target ₹530 · SL hit
- BUY — Vaishali Parekh, Prabhudas Lilladher10 Sept 2026 · ~2 weeks · target ₹550 · Expired
- BUY — Elara Capital9 Sept 2026 · ~1 year · target ₹568 · Active
More from Madhu Bansal
- BUY Supriya Lifescience29 Sept 2026 · ~2 weeks · target ₹1,078 · SL hit
- BUY Supreme Petrochem29 Sept 2026 · ~2 weeks · target ₹957 · SL hit
- BUY Poonawalla Fincorp18 Sept 2026 · ~2 weeks · target ₹486 · Target hit
- BUY Prudent Corporate Advisory Services18 Sept 2026 · ~3 months · target ₹3,762 · SL hit
- BUY Sun Pharma Advanced Research Company17 Sept 2026 · ~2 weeks · target ₹208 · Target hit

